Kessler T - Search Results

1

Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision.

Schmidt LH, Vietmeier B, Kaleschke G, Schülke C, Görlich D, Schliemann C, Kessler T, Schulze AB, Buerke B, Kuemmel A, Thrull M, Wiewrodt R, Baumgartner H, Berdel WE, Mohr M. Schmidt LH, et al. Among authors: kessler t. PLoS One. 2016 May 12;11(5):e0155398. doi: 10.1371/journal.pone.0155398. eCollection 2016. PLoS One. 2016. PMID: 27171441 Free PMC article.

2

[Angiogenesis in patients with hematologic malignancies].

Mesters RM, Padró T, Steins M, Bieker R, Retzlaff S, Kessler T, Kienast J, Berdel WE. Mesters RM, et al. Among authors: kessler t. Onkologie. 2001 Sep;24 Suppl 5:75-80. doi: 10.1159/000055192. Onkologie. 2001. PMID: 11600818 Review. German.

3

Efficacy and safety of thalidomide in patients with acute myeloid leukemia.

Steins MB, Padró T, Bieker R, Ruiz S, Kropff M, Kienast J, Kessler T, Buechner T, Berdel WE, Mesters RM. Steins MB, et al. Among authors: kessler t. Blood. 2002 Feb 1;99(3):834-9. doi: 10.1182/blood.v99.3.834. Blood. 2002. PMID: 11806984 Free article. Clinical Trial.

4

Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.

Padró T, Bieker R, Ruiz S, Steins M, Retzlaff S, Bürger H, Büchner T, Kessler T, Herrera F, Kienast J, Müller-Tidow C, Serve H, Berdel WE, Mesters RM. Padró T, et al. Among authors: kessler t. Leukemia. 2002 Jul;16(7):1302-10. doi: 10.1038/sj.leu.2402534. Leukemia. 2002. PMID: 12094254 Clinical Trial.

5

Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategies.

Kessler TA, Pfeifer A, Silletti S, Mesters RM, Berdel WE, Verma I, Cheresh D. Kessler TA, et al. Ann Hematol. 2002;81 Suppl 2:S69-70. Ann Hematol. 2002. PMID: 12611083

6

Rituximab in combination with platinum-containing chemotherapy in patients with relapsed or primary refractory diffuse large B-cell lymphoma.

Bieker R, Kessler T, Berdel WE, Mesters RM. Bieker R, et al. Among authors: kessler t. Oncol Rep. 2003 Nov-Dec;10(6):1915-7. doi: 10.3892/or.10.6.1915. Oncol Rep. 2003. PMID: 14534718

7

Thalidomide for the treatment of acute myeloid leukemia.

Steins MB, Bieker R, Padró T, Kessler T, Kienast J, Berdel WE, Mesters RM. Steins MB, et al. Among authors: kessler t. Leuk Lymphoma. 2003 Sep;44(9):1489-93. doi: 10.3109/10428190309178769. Leuk Lymphoma. 2003. PMID: 14565649 Review.

8

Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia.

Bieker R, Padró T, Kramer J, Steins M, Kessler T, Retzlaff S, Herrera F, Kienast J, Berdel WE, Mesters RM. Bieker R, et al. Among authors: kessler t. Cancer Res. 2003 Nov 1;63(21):7241-6. Cancer Res. 2003. PMID: 14612519

9

Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.

Kessler T, Bieker R, Padró T, Schwöppe C, Persigehl T, Bremer C, Kreuter M, Berdel WE, Mesters RM. Kessler T, et al. Clin Cancer Res. 2005 Sep 1;11(17):6317-24. doi: 10.1158/1078-0432.CCR-05-0389. Clin Cancer Res. 2005. PMID: 16144936

10

Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.

Schliemann C, Bieker R, Padro T, Kessler T, Hintelmann H, Buchner T, Berdel WE, Mesters RM. Schliemann C, et al. Among authors: kessler t. Haematologica. 2006 Sep;91(9):1203-11. Haematologica. 2006. PMID: 16956819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

743 results

Search Page

Filters